eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Janssen-Cilag Ltd

50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 18/08/2010
PIL Leustat Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/08/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 18/07/2008 and displayed until 18/08/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change of licence holder
Updated on 15/05/2008 and displayed until 18/07/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 13/11/2006 and displayed until 15/05/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to date of revision
Updated on 07/11/2006 and displayed until 13/11/2006
Reasons for adding or updating:
  • Change of manufacturer
Updated on 31/03/2004 and displayed until 07/11/2006
Reasons for adding or updating:
  • Change to storage instructions
Updated on 03/01/2001 and displayed until 31/03/2004
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   cladribine